← Evidence map

ArticleEJNMMI research2019

Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST.

Lucas Goldfarb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

94 papers cite itlatest 60 shown

2019
2022
2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 30694399